FR EN
MI COMMUNITY
Our aim is simple: to position ourselves upstream of the diagnosis and to propose innovative treatments to patients

Emmanuelle CHARAFE-JAUFFRET
AMU, IPC, CRCM

MI COMMUNITY
A therapeutic revolution is happening.

Bertrand NADEL
CIML, Institut Carnot CALYM, Cancéropole PACA

MI COMMUNITY
MI both accelerates research and development in immuno-oncology and offers cancer patients more options in terms of diagnostics and treatments, as well as more innovative clinical trials.

Fabrice BARLESI
AMU, Gustave Roussy, The Pioneer Project

MI COMMUNITY
MI today is a great accomplishment as it brings together for the first time all the expertise in immunology but it is above a new strategic step for all Marseille immunology players

Cathy LAPORTE
Marseille Immunopôle

MI COMMUNITY
As such, we are involved in the Marseille immunology biotope

Michel MANCIS
Protisvalor

MI COMMUNITY
Marseille Immunopole is born from the will of all partners to do even better and progress faster, and thus allow patients always to keep one step ahead of the disease.

Éric VIVIER
AMU, AP-HM, CIML, INNATE PHARMA

Newsletter
Stay informed
Subscribe
MI COMMUNITY
“Projects like PIONeeR allow us to contribute to the understanding of resistance to immunotherapy while opening clinical research to patients in Corsica, who, until recently, had no choice other than to fly to Marseille or Paris for such opportunities.”

Stéphane PROVENT
Centre Hospitalier, Clinique Maymard, Bastia

MI COMMUNITY
By creating this super innovation centre "outside the walls", which is Marseille Immunopole, we leverage our capabilities to ensure better and faster innovation.

Bruno LACARELLE
AP-HM, AMU

MI COMMUNITY
The thrust of MI is the ability of Marseille researchers, clinicians and industrials to play as a team.

Hervé BRAILLY
Innate Pharma

MI COMMUNITY
For many years our service at the Timone Hospital has collaborated with researchers including the " Natural Killer Cells and Innate Immunity" team of Eric VIVIER .

Nicolas SCHLEINITZ
AP-HM, AMU

Update of The Pioneer Project : 395 patients in the biomarker program, 54 patients in the umbrella clinical trial Read more
MI COMMUNITY
Veracyte (formerly HaliodDx) is a key player in the MI ecosystem that allows both personalized immunotherapies utilization and acceleration of their development.

Vincent FERT
Veracyte

MI COMMUNITY
Today Marseille Immunopôle is a great opportunity to challenge our discipline with novel perspectives.

Daniel OLIVE
AMU, IPC, CRCM

MI COMMUNITY
Diagnostic in immuno-oncology is an innovative field combining the latest discoveries in immunology and new imaging technologies, such as digital pathology.

Fabienne HERMITTE
HalioDx

MI COMMUNITY
Being primarily centred on the patient, my work combines the short-term management of the disease and the long-term of clinical research.

Catherine FARNARIER
AP-HM